# Tyson Bio breaks ground on new plant in Zhubei Biomedical Park

Tyson Bio (Taiwan) held a groundbreaking ceremony on May 7, 2020 for a new plant in the Zhubei Biomedical Park, Hsinchu. The investment is NT$1 billion (approx. US$33 million) and the plant will be automated and intelligent, producing in-vitro diagnostic devices.

- Type: Expansion
- Announced: 2020-05-07
- Where: Zhubei Biomedical Park, Hsinchu, TWN
- Value: $33.0M (1.00B TWD)
- Status: under construction
- Products: in-vitro diagnostic devices, glucose monitoring systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Tyson Bio](https://endata.com/companies/47064.md)

## Sources

- [tysonbio.com](https://www.tysonbio.com/zh/index.php/news/36-tysonbio-new-plant), 2020-05-07: "台欣生技今（7）日舉行新廠開工典禮，新廠將全面導入自動化、智能化、節能化。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.